Cultural Competency in USU Extension: Impact of Professional Development for Latino Outreach Programs

In response to the growing Latino population in Utah, USU Extension faculty participated in trainings to build their cultural competency and engage with Latino audiences. The professional development series were attended by 186 Extension professionals. A 2021 follow-up study reported that 52% of respondents who participated in the training are currently engaging in Latino outreach programs

Collaborating Across State Lines to Leverage Cultural Competency Expertise

A statewide need for Latino cultural competency training for Utah State University (USU) Extension personnel was identified. The solution involved the collaborative efforts of our team of two USU Extension faculty members and one Washington State University (WSU) Extension faculty member on adaption and customization of a needs assessment tool and a training program originated at WSU. Our collaboration leveraged important limited resources such as subject-matter expertise, training materials, time, and funding while providing a venue for feedback and ideas to improve, update, and enhance an existing program. Garnering administrative support from the start is key to successful cross-state collaborative work and implementation of specialized training to expand Latino outreach capacity in Extension

Insectos cara de gato

Hay una serie de insectos con el hábito alimenticio de perforar y succionar que pueden causar deformidad y lesiones del tipo cara de gato en los frutales de pepita y hueso, como la chinche ligus, la chinche hedionda y la chinche del boxelder. La lesión cara de gato es causada cuando la chinche se alimenta agujerando los botones florales y la fruta. El resultado son depresiones, deformidades y cicatrices desagradables en la fruta. El nombre “cara de gato” proviene de la forma distorsionada de la fruta que se asemeja a las mejillas fruncidas de un gato. Además de los insectos mencionados en esta sección, algunos pulgones y la chinche campylomma pueden causar lesiones similares

Barrenador grande del durazno

El barrenador grande del durazno (orden Lepidóptera, familia Sesiidae) es originario de América del Norte, donde las cerezas y ciruelas silvestres son sus huéspedes nativos. Es una plaga esporádica en los frutales de hueso o carozo de Utah, pero si no se controla, puede ser lo suficientemente grave como para causar la pérdida del árbol

Higher Education: How Parents Can Support Their Children

This fact sheet gives tips on how parents can support their children in the process of understand and evaluating college and career opportunities in higher education

Plagas de orugas de vegetales del género Brassica

Los cultivos de Brassica albergan muchas plagas de insectos diferentes, inclusive varias especies de orugas. Los tres más comunes en Utah son la palomilla dorso de diamante (Plutella xylostella), la oruga de la col (Trichoplusia ni), y el gusano importado de las coles (Pieris rapae)

Manejo de la Chinche Hedionda Marrón Marmolada para Frutas y Hortalizas en Utah

La chinche hedionda marrón marmolada es una plaga molesta y conómicamente importante para la agricultura que invadió Norteamérica desde el este de Asia a fines de la década de 1990

Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study

Background: Up to 30% of hospitalised patients with COVID-19 require advanced respiratory support, including high-flow nasal cannulas (HFNC), non-invasive mechanical ventilation (NIV), or invasive mechanical ventilation (IMV). We aimed to describe the clinical characteristics, outcomes and risk factors for failing non-invasive respiratory support in patients treated with severe COVID-19 during the first two years of the pandemic in high-income countries (HICs) and low middle-income countries (LMICs). Methods: This is a multinational, multicentre, prospective cohort study embedded in the ISARIC-WHO COVID-19 Clinical Characterisation Protocol. Patients with laboratory-confirmed SARS-CoV-2 infection who required hospital admission were recruited prospectively. Patients treated with HFNC, NIV, or IMV within the first 24 h of hospital admission were included in this study. Descriptive statistics, random forest, and logistic regression analyses were used to describe clinical characteristics and compare clinical outcomes among patients treated with the different types of advanced respiratory support. Results: A total of 66,565 patients were included in this study. Overall, 82.6% of patients were treated in HIC, and 40.6% were admitted to the hospital during the first pandemic wave. During the first 24 h after hospital admission, patients in HICs were more frequently treated with HFNC (48.0%), followed by NIV (38.6%) and IMV (13.4%). In contrast, patients admitted in lower- and middle-income countries (LMICs) were less frequently treated with HFNC (16.1%) and the majority received IMV (59.1%). The failure rate of non-invasive respiratory support (i.e. HFNC or NIV) was 15.5%, of which 71.2% were from HIC and 28.8% from LMIC. The variables most strongly associated with non-invasive ventilation failure, defined as progression to IMV, were high leukocyte counts at hospital admission (OR [95%CI]; 5.86 [4.83-7.10]), treatment in an LMIC (OR [95%CI]; 2.04 [1.97-2.11]), and tachypnoea at hospital admission (OR [95%CI]; 1.16 [1.14-1.18]). Patients who failed HFNC/NIV had a higher 28-day fatality ratio (OR [95%CI]; 1.27 [1.25-1.30]). Conclusions: In the present international cohort, the most frequently used advanced respiratory support was the HFNC. However, IMV was used more often in LMIC. Higher leucocyte count, tachypnoea, and treatment in LMIC were risk factors for HFNC/NIV failure. HFNC/NIV failure was related to worse clinical outcomes, such as 28-day mortality. Trial registration This is a prospective observational study; therefore, no health care interventions were applied to participants, and trial registration is not applicable

Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study

Background: Up to 30% of hospitalised patients with COVID-19 require advanced respiratory support, including high-flow nasal cannulas (HFNC), non-invasive mechanical ventilation (NIV), or invasive mechanical ventilation (IMV). We aimed to describe the clinical characteristics, outcomes and risk factors for failing non-invasive respiratory support in patients treated with severe COVID-19 during the first two years of the pandemic in high-income countries (HICs) and low middle-income countries (LMICs). Methods: This is a multinational, multicentre, prospective cohort study embedded in the ISARIC-WHO COVID-19 Clinical Characterisation Protocol. Patients with laboratory-confirmed SARS-CoV-2 infection who required hospital admission were recruited prospectively. Patients treated with HFNC, NIV, or IMV within the first 24 h of hospital admission were included in this study. Descriptive statistics, random forest, and logistic regression analyses were used to describe clinical characteristics and compare clinical outcomes among patients treated with the different types of advanced respiratory support. Results: A total of 66,565 patients were included in this study. Overall, 82.6% of patients were treated in HIC, and 40.6% were admitted to the hospital during the first pandemic wave. During the first 24 h after hospital admission, patients in HICs were more frequently treated with HFNC (48.0%), followed by NIV (38.6%) and IMV (13.4%). In contrast, patients admitted in lower- and middle-income countries (LMICs) were less frequently treated with HFNC (16.1%) and the majority received IMV (59.1%). The failure rate of non-invasive respiratory support (i.e. HFNC or NIV) was 15.5%, of which 71.2% were from HIC and 28.8% from LMIC. The variables most strongly associated with non-invasive ventilation failure, defined as progression to IMV, were high leukocyte counts at hospital admission (OR [95%CI]; 5.86 [4.83–7.10]), treatment in an LMIC (OR [95%CI]; 2.04 [1.97–2.11]), and tachypnoea at hospital admission (OR [95%CI]; 1.16 [1.14–1.18]). Patients who failed HFNC/NIV had a higher 28-day fatality ratio (OR [95%CI]; 1.27 [1.25–1.30]). Conclusions: In the present international cohort, the most frequently used advanced respiratory support was the HFNC. However, IMV was used more often in LMIC. Higher leucocyte count, tachypnoea, and treatment in LMIC were risk factors for HFNC/NIV failure. HFNC/NIV failure was related to worse clinical outcomes, such as 28-day mortality. Trial registration This is a prospective observational study; therefore, no health care interventions were applied to participants, and trial registration is not applicable